vs

Side-by-side financial comparison of Capri Holdings Ltd (CPRI) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Capri Holdings Ltd is the larger business by last-quarter revenue ($1.0B vs $719.4M, roughly 1.4× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 11.3%, a 61.9% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -18.7%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $183.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -15.2%).

Capri Holdings Limited is a multinational fashion holding company, incorporated in the British Virgin Islands, with executive offices in London and operational offices in New York. It was founded in 1981 by American designer Michael Kors. The company sells clothes, shoes, watches, handbags, and other accessories. In 2015, the company had more than 550 stores and over 1,500 in-store boutiques in various countries.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

CPRI vs DOC — Head-to-Head

Bigger by revenue
CPRI
CPRI
1.4× larger
CPRI
$1.0B
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+21.8% gap
DOC
3.1%
-18.7%
CPRI
Higher net margin
DOC
DOC
61.9% more per $
DOC
73.2%
11.3%
CPRI
More free cash flow
DOC
DOC
$174.0M more FCF
DOC
$357.0M
$183.0M
CPRI
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-15.2%
CPRI

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CPRI
CPRI
DOC
DOC
Revenue
$1.0B
$719.4M
Net Profit
$116.0M
$114.0M
Gross Margin
60.8%
Operating Margin
4.5%
17.4%
Net Margin
11.3%
73.2%
Revenue YoY
-18.7%
3.1%
Net Profit YoY
121.2%
2406.4%
EPS (diluted)
$0.96
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPRI
CPRI
DOC
DOC
Q4 25
$1.0B
$719.4M
Q3 25
$856.0M
$705.9M
Q2 25
$797.0M
$694.3M
Q1 25
$1.6B
$702.9M
Q4 24
$1.1B
$698.0M
Q3 24
$878.0M
$700.4M
Q2 24
$848.0M
$695.5M
Q1 24
$606.6M
Net Profit
CPRI
CPRI
DOC
DOC
Q4 25
$116.0M
$114.0M
Q3 25
$-28.0M
$-117.1M
Q2 25
$53.0M
$31.7M
Q1 25
$-645.0M
$42.8M
Q4 24
$-547.0M
$4.5M
Q3 24
$24.0M
$85.9M
Q2 24
$-14.0M
$146.0M
Q1 24
$6.7M
Gross Margin
CPRI
CPRI
DOC
DOC
Q4 25
60.8%
Q3 25
61.0%
58.6%
Q2 25
63.0%
60.2%
Q1 25
64.9%
61.1%
Q4 24
63.1%
60.3%
Q3 24
62.3%
60.0%
Q2 24
63.1%
60.6%
Q1 24
59.8%
Operating Margin
CPRI
CPRI
DOC
DOC
Q4 25
4.5%
17.4%
Q3 25
-1.4%
9.2%
Q2 25
2.0%
5.7%
Q1 25
-47.5%
7.7%
Q4 24
2.4%
-2.2%
Q3 24
-0.7%
14.1%
Q2 24
1.3%
22.3%
Q1 24
3.7%
Net Margin
CPRI
CPRI
DOC
DOC
Q4 25
11.3%
73.2%
Q3 25
-3.3%
-16.6%
Q2 25
6.6%
4.6%
Q1 25
-39.1%
6.1%
Q4 24
-51.2%
0.7%
Q3 24
2.7%
12.3%
Q2 24
-1.7%
21.0%
Q1 24
1.1%
EPS (diluted)
CPRI
CPRI
DOC
DOC
Q4 25
$0.96
$0.16
Q3 25
$-0.22
$-0.17
Q2 25
$0.44
$0.05
Q1 25
$-5.47
$0.06
Q4 24
$-4.61
$0.02
Q3 24
$0.20
$0.12
Q2 24
$-0.12
$0.21
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPRI
CPRI
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$154.0M
$467.5M
Total DebtLower is stronger
$234.0M
$9.8B
Stockholders' EquityBook value
$105.0M
$7.5B
Total Assets
$3.3B
$20.3B
Debt / EquityLower = less leverage
2.23×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPRI
CPRI
DOC
DOC
Q4 25
$154.0M
$467.5M
Q3 25
$120.0M
$91.0M
Q2 25
$129.0M
$89.4M
Q1 25
$107.0M
$70.6M
Q4 24
$356.0M
$119.8M
Q3 24
$182.0M
$180.4M
Q2 24
$213.0M
$106.9M
Q1 24
$101.8M
Total Debt
CPRI
CPRI
DOC
DOC
Q4 25
$234.0M
$9.8B
Q3 25
$1.8B
$9.1B
Q2 25
$1.7B
$9.0B
Q1 25
$1.5B
$8.9B
Q4 24
$1.5B
$8.7B
Q3 24
$1.7B
$8.6B
Q2 24
$1.7B
$8.6B
Q1 24
$8.8B
Stockholders' Equity
CPRI
CPRI
DOC
DOC
Q4 25
$105.0M
$7.5B
Q3 25
$-74.0M
$7.6B
Q2 25
$-17.0M
$7.9B
Q1 25
$368.0M
$8.2B
Q4 24
$1.1B
$8.4B
Q3 24
$1.5B
$8.6B
Q2 24
$1.6B
$8.8B
Q1 24
$8.9B
Total Assets
CPRI
CPRI
DOC
DOC
Q4 25
$3.3B
$20.3B
Q3 25
$5.6B
$19.6B
Q2 25
$5.5B
$19.8B
Q1 25
$5.2B
$19.8B
Q4 24
$5.9B
$19.9B
Q3 24
$6.8B
$20.0B
Q2 24
$6.6B
$20.2B
Q1 24
$20.5B
Debt / Equity
CPRI
CPRI
DOC
DOC
Q4 25
2.23×
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
4.05×
1.08×
Q4 24
1.38×
1.04×
Q3 24
1.15×
1.00×
Q2 24
1.08×
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPRI
CPRI
DOC
DOC
Operating Cash FlowLast quarter
$202.0M
$1.3B
Free Cash FlowOCF − Capex
$183.0M
$357.0M
FCF MarginFCF / Revenue
17.9%
49.6%
Capex IntensityCapex / Revenue
1.9%
124.4%
Cash ConversionOCF / Net Profit
1.74×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$-134.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPRI
CPRI
DOC
DOC
Q4 25
$202.0M
$1.3B
Q3 25
$-52.0M
$315.0M
Q2 25
$-8.0M
$363.5M
Q1 25
$-161.0M
$279.4M
Q4 24
$309.0M
$1.1B
Q3 24
$50.0M
$318.2M
Q2 24
$83.0M
$316.2M
Q1 24
$152.6M
Free Cash Flow
CPRI
CPRI
DOC
DOC
Q4 25
$183.0M
$357.0M
Q3 25
$-65.0M
Q2 25
$-21.0M
Q1 25
$-231.0M
Q4 24
$287.0M
$333.7M
Q3 24
$30.0M
Q2 24
$67.0M
Q1 24
FCF Margin
CPRI
CPRI
DOC
DOC
Q4 25
17.9%
49.6%
Q3 25
-7.6%
Q2 25
-2.6%
Q1 25
-14.0%
Q4 24
26.9%
47.8%
Q3 24
3.4%
Q2 24
7.9%
Q1 24
Capex Intensity
CPRI
CPRI
DOC
DOC
Q4 25
1.9%
124.4%
Q3 25
1.5%
Q2 25
1.6%
Q1 25
4.2%
Q4 24
2.1%
105.6%
Q3 24
2.3%
Q2 24
1.9%
Q1 24
Cash Conversion
CPRI
CPRI
DOC
DOC
Q4 25
1.74×
10.99×
Q3 25
Q2 25
-0.15×
11.48×
Q1 25
6.52×
Q4 24
235.43×
Q3 24
2.08×
3.71×
Q2 24
2.17×
Q1 24
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPRI
CPRI

Michael Kors Segment$593.0M58%
Other$379.0M37%
Jimmy Choo Segment$53.0M5%

DOC
DOC

Segment breakdown not available.

Related Comparisons